Atlas Trials

Comparison of Pharmacodynamic Effects of Sotagliflozin and Empagliflozin in T2DM Patients With Mild to Moderate Hypertension

Clinical trial NCT03462069 · COMPLETED

Trial details

NCT number
NCT03462069
Sponsor
Sanofi
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Diabetes Mellitus
Start date
2018-03-12
Primary completion
2019-04-18
Enrollment
41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.